Clinuvel Pharmaceuticals (UR9A.F) Q1 2023 Earnings

Feb 24Confirmed
Q3 2021
Q1 2022
Q3 2022
Q1 2023
0.07
0.12
0.17
0.22

Details

Expected EPS
0.1970133331467435
Actual EPS
0.13981591384607603
Surprise EPS
-0.06
Surprise Percent
-29.03%

Description

⁨Clinuvel Pharmaceuticals⁩ (⁦UR9A.F⁩) has reported earnings of ⁦0.13981591384607603⁩ per share for ⁦Q1 2023⁩.

0 Comments

Share your thoughts